Cite
HARVARD Citation
Polonsky, W. et al. (2022). Improved patient‐reported outcomes with iGlarLixi versus premix BIAsp 30 in people with type 2 diabetes in the SoliMix trial. Diabetes, obesity & metabolism. 24 (12), pp. 2364-2372. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Polonsky, W. et al. (2022). Improved patient‐reported outcomes with iGlarLixi versus premix BIAsp 30 in people with type 2 diabetes in the SoliMix trial. Diabetes, obesity & metabolism. 24 (12), pp. 2364-2372. [Online].